» Articles » PMID: 4049246

Carcinoma of the Extrahepatic Bile Ducts: Results of an Aggressive Surgical Approach

Overview
Journal Surgery
Specialty General Surgery
Date 1985 Oct 1
PMID 4049246
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Ninety patients with adenocarcinoma of the extrahepatic bile ducts were treated between 1969 and 1984. Fifty-four tumors involved the upper third, 15 the middle third, and 21 the lower third of the common duct. Twenty-two patients had gallstones and five had inflammatory bowel disease. Forty-three patients had operations before definitive treatment; the diagnosis was made in only 18. Resection was accomplished in 30 patients (33%): 12 of 54 in the proximal third, six of 15 in the middle third, and 12 of 21 in the distal third. The mean survival in patients who underwent resection was 32 months (proximal third, 28 months; middle third, 32 months; lower third, 37 months). Surgical bypass was performed in 28 patients (mean survival 10 months) and intubation alone was performed in 24 patients (mean survival 8 months). Recurrent cholangitis occurred in 56% of intubated patients compared with 26% of patients treated without tubes. Radiation was used with resection and for palliation. Responses were observed, but the complication of radiation duodenitis has limited the dose. An aggressive approach to resection of bile duct tumors is possible with a low operative mortality rate and offers the best opportunity for cure as well as good palliation. Internal bypass is preferable to chronic intubation. The role of radiation therapy in this disease is still not clear.

Citing Articles

High dose chemoradiation for unresectable hilar cholangiocarcinomas using intensity modulated external beam radiotherapy: a single tertiary care centre experience.

Engineer R, Mehta S, Kalyani N, Chaudhari S, Dharia T, Shetty N J Gastrointest Oncol. 2017; 8(1):180-186.

PMID: 28280622 PMC: 5334046. DOI: 10.21037/jgo.2017.01.20.


Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma.

Isayama H, Tsujino T, Nakai Y, Sasaki T, Nakagawa K, Yamashita H World J Gastroenterol. 2012; 18(19):2364-70.

PMID: 22654427 PMC: 3353370. DOI: 10.3748/wjg.v18.i19.2364.


Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study.

Lim K, Oh D, Chie E, Jang J, Im S, Kim T BMC Cancer. 2009; 9:345.

PMID: 19781103 PMC: 2761944. DOI: 10.1186/1471-2407-9-345.


Radiation therapy and photodynamic therapy for biliary tract and ampullary carcinomas.

Saito H, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M J Hepatobiliary Pancreat Surg. 2008; 15(1):63-8.

PMID: 18274845 PMC: 2794340. DOI: 10.1007/s00534-007-1281-y.


Flowcharts for the management of biliary tract and ampullary carcinomas.

Miyakawa S, Ishihara S, Takada T, Miyazaki M, Tsukada K, Nagino M J Hepatobiliary Pancreat Surg. 2008; 15(1):7-14.

PMID: 18274839 PMC: 2794355. DOI: 10.1007/s00534-007-1275-9.